Johnson Chemical Pharmaceutical Works Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Pai-Hsiung Huang
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 25.9yrs |
| CEO ownership | n/a |
| Management average tenure | 14.9yrs |
| Board average tenure | no data |
Recent management updates
Recent updates
Could Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Have The Makings Of Another Dividend Aristocrat?
Mar 25
These 4 Measures Indicate That Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Using Debt Reasonably Well
Feb 18Weak Financial Prospects Seem To Be Dragging Down Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Stock
Feb 01Estimating The Fair Value Of Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747)
Jan 12
Is Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) An Attractive Dividend Stock?
Dec 25Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Growing Earnings But Are They A Good Guide?
Dec 07CEO
Pai-Hsiung Huang
25.9yrs
Tenure
Mr. Pai-Hsiung Huang serves as Chairman at Johnson Chemical Pharmaceutical Works Co. Ltd. and serves as its Chief executive officer since 1999. Mr. Huang began his career with JCP in 1972 as a sales assist...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 25.9yrs | no data | no data | |
| Finance Director | 10.8yrs | no data | no data | |
| Accounting Supervisor | no data | no data | no data | |
| Sales Director | 14.9yrs | no data | no data | |
| Deputy General Manager and Director | no data | no data | 6.7% NT$ 215.6m | |
| Chief Research Officer | no data | no data | no data |
14.9yrs
Average Tenure
Experienced Management: 4747's management team is seasoned and experienced (14.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 13:04 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Johnson Chemical Pharmaceutical Works Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Regina Lee | Capital Securities Corporation |